Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Urticaria

• Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)
• Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
• Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria
• A Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo and With Omalizumab as Active Control in CSU Adult Patients.
• A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
• A Single Dose, Phase 1 Study of YH35324 in Patients With Various Allergic Diseases
• Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
• A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.
• Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
• 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Y
• A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria
• A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) or Chronic Inducible Cold Urticaria (CICU) (LIBERTY-CSU/CINDU CUPIDKids)
• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib
• A Study to Evaluate THB001 in Adult Patients With Chronic Cold Urticaria
• Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares
• Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%
• A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
• Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.
• A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
• A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria
• A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria
• Using Doxepin for Urticaria
• Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to Omalizumab
• A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines
• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1- Antihistamines
• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines
• Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines
• Modified Xiao-Feng Powder for Chronic Urticaria
• Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children
• Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria
• Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
• Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria
• Molecular Endotypes of Chronic Idiopathic Urticaria
• Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
• A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria
• A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
• Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria
• A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
• Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients
• Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab
• Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab
• Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria
• A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
• Open-label, Multicenter, Extension Study to Evaluate Long-term Safety and Tolerability of LOU064 in Subjects With CSU
• A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria
• Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
• A Study to Assess the Efficacy, Safety and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases
• Tranexamic Acid and Spontaneous Chronic Urticaria
• Cholinergic Urticaria - Efficacy of Dupilumab
• Dupilumab in Chronic Spontaneous Urticaria
• A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study
• COrticosteroids in acUte uRticAria in emerGency dEpartment
• Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
• Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)
• A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria
• Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria
• Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.
• To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria
• A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).
• Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)
• Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
• High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
• Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation
• Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria
• Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency
• Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
• Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
• Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria
• Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria
• Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
• Omalizumab in Severe and Refractory Solar Urticaria
• Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria
• Bilastine Updosing in Chronic Spontaneous Urticaria
• Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria
• Cold Contact Urticaria Treatment With Rilonacept
• Urticaria Facticia Treatment With Omalizumab (UFO)
• Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria
• OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients
• Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines
• Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg
• Multicenter Pilot Phase III Clinical Trials of JDP-205 iv Injection for the Treatment of Acute Urticaria Associated With an Acute Allergic Reaction.
• A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria
• Methotrexate in the Treatment of Chronic Idiopathic Urticaria
• Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria
• An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)
• PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg
• Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
• Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy
• Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria
• Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
• Efficacy Study of Canakinumab to Treat Urticaria
• Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria
• Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
• Safety Study of Levocetirizine and Fexofenadine
• Cold Urticaria Treatment With Xolair
• Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria
• The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
• Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria
• A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)
• A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment
• Bilastine Updosing - Characterization of Underlying Mechanisms
• A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists
• Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses
• Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria
• Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses
• Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)
• Hydroxychloroquine Efficacy in Chronic Urticaria
• Etanercept for the Treatment of Chronic Urticaria
• The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism
• Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy
• A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)
• Phase II Solar Urticaria (SU) Pilot Study
• An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)
• How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988)
• A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
• Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
• Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)
• Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)
• A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)
• A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)
• Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria
• Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin
• A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions
• Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)
• Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)
• Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria
• Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)
• Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria
• Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria
• The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
• Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
• CUTE (Chronic Urticaria Treatment Evaluation)
• Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
• The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
• Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria
• Efficacy of Rupatadine 5, 10 and 20 Mg in Chronic Idiopathic Urticaria
• A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria
• Effect of Anti-IgE in Chronic Urticaria
• Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease